Advertisement

Topics

AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results

16:03 EST 28 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
2016 revenue of $155.1 million – up 19.5% 2016 U.S. sales of $122.4 million – up 19.7% 2016 International sales of $32.7 million – up 18.8% AtriCure, Inc. (Nasdaq: ...

Other Sources for this Article

AtriCure, Inc.
Andy Wade, 513-755-4564
Senior Vice President and Chief Financial Officer
awade@atricure.com
or
Gilmartin Group
Lynn Pieper Lewis, 415-937-5402
Investor Relations
lynn@gilmartinir.com

NEXT ARTICLE

More From BioPortfolio on "AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...